Abstract

Primary hepatic squamous cell carcinoma (SCC) is a rare malignancy with aggressive clinical features. This is the first case report of a primary hepatic SCC diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), which is a reliable and safe procedure for the histopathological diagnosis of liver lesions, even if the percutaneous approach is difficult due to ascites or hypervascularity at the puncture site. A 52-year-old man presented to the emergency department of a tertiary referral hospital with right upper quadrant abdominal pain and abdominal distention. Given the laboratory data, a diagnosis of spontaneous bacterial peritonitis (SBP) was made. Concurrently, an abdominal computed tomography (CT) scan revealed an 8 cm hypodense mass with delayed peripheral enhancement in the left hepatic lobe and paraaortic and perihepatic lymphadenopathy. As persistent ascites precluded percutaneous liver biopsy, we performed EUS-FNA of the liver mass, and the obtained specimen showed SCC. As otorhinolaryngological consultation and whole-body investigations, including chest CT, upper and lower endoscopy, and positron emission tomography CT, were all unremarkable except for the liver lesion and lymph nodes, a diagnosis of primary hepatic SCC with systemic lymph node metastasis was made. After treatment of SBP with antibiotics, we initiated chemotherapy concurrent with radiation therapy, adapted to his liver function. Radiation and three cycles of chemotherapy were not effective as the disease progressed, as seen on the follow-up CT scan, and the patient died of hepatic failure on the 134th day after diagnosis. In conclusion, EUS-FNA was a reliable method for tissue sampling in liver malignancies, particularly in selected patients with contraindications for percutaneous biopsy.

Highlights

  • Histopathologic examination of biopsy specimens obtained from atypical liver masses is known to provide essential diagnostic information, significantly improving patient care [1]

  • Multiple articles regarding endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of the liver have been published, and according to the studies, EUS-FNA has had equivalent efficacy and safety compared with percutaneous liver biopsy [1]. is is the first case report of a hepatic squamous cell carcinoma (SCC) diagnosed by EUS-FNA in a patient with hepatic cirrhosis

  • A computed tomography (CT) scan with intravenous (IV) contrast revealed hypodense hepatic masses with peripheral delayed enhancement. e masses in the left and right hepatic lobes measured 8 cm and 2 cm, respectively. e CT scan showed moderate ascites and paraaortic and perihepatic lymphadenopathy (Figure 1(b)). Marked hyperintensity of both the left and right hepatic lobe masses was revealed on diffusionweighted magnetic resonance imaging (MRI), while peripheral arterial enhancement was seen on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI (Figures 2(a)–2(d))

Read more

Summary

Introduction

Histopathologic examination of biopsy specimens obtained from atypical liver masses is known to provide essential diagnostic information, significantly improving patient care [1]. Percutaneous liver biopsy is limited by ascites or coagulopathy secondary to poor liver function. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) has been a reliable method for diagnosing intraabdominal masses [2]. Multiple articles regarding EUS-FNA of the liver have been published, and according to the studies, EUS-FNA has had equivalent efficacy and safety compared with percutaneous liver biopsy [1]. Is is the first case report of a hepatic squamous cell carcinoma (SCC) diagnosed by EUS-FNA in a patient with hepatic cirrhosis Multiple articles regarding EUS-FNA of the liver have been published, and according to the studies, EUS-FNA has had equivalent efficacy and safety compared with percutaneous liver biopsy [1]. is is the first case report of a hepatic squamous cell carcinoma (SCC) diagnosed by EUS-FNA in a patient with hepatic cirrhosis

Case Presentation
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call